Efficacy of Plinabulin vs Pegfilgrastim for Prevention of Chemotherapy-Induced Neutropenia in Adults With Non–Small Cell Lung Cancer A Phase 2 Randomized Clinical Trial
Plinabulin ameliorates neutropenia induced by multiple chemotherapies through a mechanism distinct from G‑CSF therapies
Structure, Thermodynamics, and Kinetics of Plinabulin Binding to Two Tubulin Isotypes
GEF-H1 Signaling upon Microtubule Destabilization Is Required for Dendritic Cell Activation and Specific Anti-Tumor Responses
Phase 1 Study of the Novel Vascular Disrupting Agent Plinabulin (NPI-2358) and Docetaxel
© 2020 BeyondSpring Inc. All rights reserved.
